Real time monitoring of blood propofol concentratio
Phase 1
- Conditions
- - General anaesthesia- Pharmacokinetics and Pharmacodynamics of Propofol- Inflammatory parameters- Elective thyroid, oncologic breast,ENT or cervical arthrodesis surgeryTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2015-000537-69-BE
- Lead Sponsor
- niversitair Ziekenhuis Brussel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- >18-70 years
- ASA I, II
- Weight not exceeding 50 % under or above normal ideal body weight
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 25
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 5
Exclusion Criteria
- Pregnancy
- ASA III and ASA IV
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method